Mouse Colon Carcinoma CT26.WT Transfection Kit

Description

CT26.WT is a cell line that was derived from a mouse colon carcinoma. They also exhibit a number of genetic and molecular abnormalities that are commonly found in colon cancer cells, including mutations in the APC and p53 genes. These mutations contribute to the development and progression of the cancer by disrupting normal cell growth and division, promoting the growth of blood vessels that feed the tumor, and inhibiting the immune system's ability to recognize and eliminate cancer cells. Researchers use CT26.WT cells to study the mechanisms underlying the development and progression of colon cancer, as well as to test the efficacy and safety of new therapies for this disease. The insights gained from these studies can help to improve our understanding of colon cancer and lead to the development of more effective treatments for this common and deadly disease in humans. In order to undertake comprehensive and nuanced explorations, it is absolutely critical to have a cell transfection system that is both effective and targeted in its approach. With this in mind, the scientific experts at CD BioSciences have successfully engineered a highly specialized transfection kit, specifically optimized for use with the CT26.WT cell line.